<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Allergy, Asthma and Immunology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>21</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2022</Year>
        <Month>08</Month>
        <Day>12</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Protocols of Standard of Care for Adult Patients with Primary Antibody Deficiencies Will Improve Timing of Diagnosis, Survival, and Quality of Life</title>
    <FirstPage>374</FirstPage>
    <LastPage>387</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Katarzyna</FirstName>
        <LastName>Napi&#xF3;rkowska-Baran</LastName>
        <affiliation locale="en_US">Department of Allergology, Clinical Immunology and Internal Diseases, Ludwik Rydygier Collegium Medicum in Bydgoszcz Nicolaus Copernicus University in Toru&#x144;, Bydgoszcz, Poland</affiliation>
      </Author>
      <Author>
        <FirstName>Ewa</FirstName>
        <LastName>Wi&#x119;sik-Szewczyk</LastName>
        <affiliation locale="en_US">Department of Internal Medicine, Pulmonology, Allergy and Clinical Immunology, Central Clinical Hospital of the Ministry of National Defense, Military Institute of Medicine, Warsaw, Poland</affiliation>
      </Author>
      <Author>
        <FirstName>Marcin</FirstName>
        <LastName>Zi&#x119;tkiewicz</LastName>
        <affiliation locale="en_US">Department of Internal Medicine, Connective Tissue Diseases and Geriatrics, Medical University of Gda&#x144;sk,  Gda&#x144;sk, Poland</affiliation>
      </Author>
      <Author>
        <FirstName>Aleksandra</FirstName>
        <LastName>Matyja-Bednarczyk</LastName>
        <affiliation locale="en_US">2nd Department of Internal Medicine, Jagiellonian University Medical College, Krak&#xF3;w, Poland</affiliation>
      </Author>
      <Author>
        <FirstName>Sylwia</FirstName>
        <LastName>Ko&#x142;tan</LastName>
        <affiliation locale="en_US">Department of Pediatrics, Hematology and Oncology, Ludwik Rydygier Collegium Medicum in Bydgoszcz Nicolaus Copernicus University in Toru&#x144;, Bydgoszcz, Poland</affiliation>
      </Author>
      <Author>
        <FirstName>Natalia</FirstName>
        <LastName>B&#x105;kowska-Kocik</LastName>
        <affiliation locale="en_US">Department of Clinical Oncology, Franciszek &#x141;ukaszczyk Oncology Centre, Bydgoszcz, Poland</affiliation>
      </Author>
      <Author>
        <FirstName>Tomasz</FirstName>
        <LastName>Rosada</LastName>
        <affiliation locale="en_US">Department of Allergology, Clinical Immunology and Internal Diseases, Ludwik Rydygier Collegium Medicum in Bydgoszcz Nicolaus Copernicus University in Toru&#x144;, Bydgoszcz, Poland</affiliation>
      </Author>
      <Author>
        <FirstName>Karolina</FirstName>
        <LastName>Baranowska</LastName>
        <affiliation locale="en_US">Department of Allergology, Clinical Immunology and Internal Diseases, Ludwik Rydygier Collegium Medicum in Bydgoszcz Nicolaus Copernicus University in Toru&#x144;, Bydgoszcz, Poland</affiliation>
      </Author>
      <Author>
        <FirstName>Ewa</FirstName>
        <LastName>Alska</LastName>
        <affiliation locale="en_US">Department of Allergology, Clinical Immunology and Internal Diseases, Ludwik Rydygier Collegium Medicum in Bydgoszcz Nicolaus Copernicus University in Toru&#x144;, Bydgoszcz, Poland</affiliation>
      </Author>
      <Author>
        <FirstName>Marta</FirstName>
        <LastName>Tykwi&#x144;ska</LastName>
        <affiliation locale="en_US">Department of Allergology, Clinical Immunology and Internal Diseases, Ludwik Rydygier Collegium Medicum in Bydgoszcz Nicolaus Copernicus University in Toru&#x144;, Bydgoszcz, Poland</affiliation>
      </Author>
      <Author>
        <FirstName>Ewa</FirstName>
        <LastName>Szynkiewicz</LastName>
        <affiliation locale="en_US">Department of Allergology, Clinical Immunology and Internal Diseases, Ludwik Rydygier Collegium Medicum in Bydgoszcz Nicolaus Copernicus University in Toru&#x144;, Bydgoszcz, Poland AND Department of Preventive Nursing, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru&#x144;, Bydgoszcz, Poland</affiliation>
      </Author>
      <Author>
        <FirstName>Robert</FirstName>
        <LastName>Zacniewski</LastName>
        <affiliation locale="en_US">Department of Allergology, Clinical Immunology and Internal Diseases, Ludwik Rydygier Collegium Medicum in Bydgoszcz Nicolaus Copernicus University in Toru&#x144;, Bydgoszcz, Poland</affiliation>
      </Author>
      <Author>
        <FirstName>Zbigniew</FirstName>
        <LastName>Bartuzi</LastName>
        <affiliation locale="en_US">Department of Allergology, Clinical Immunology and Internal Diseases, Ludwik Rydygier Collegium Medicum in Bydgoszcz Nicolaus Copernicus University in Toru&#x144;, Bydgoszcz, Poland</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2021</Year>
        <Month>08</Month>
        <Day>07</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2022</Year>
        <Month>04</Month>
        <Day>20</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">The majority of primary immunodeficiencies (PIDs) are antibody deficiencies (PADs), and not all of them are rare diseases; As an example, Caucasian individuals suffer from selective IgA deficiency at a frequency of 1:500.
In addition to infections, symptomatic patients with PAD are more likely to develop neoplastic, autoimmune, and allergic diseases. In the event that PAD is neglected or delayed for more than ten years, complications develop, eventually resulting in death. No studies have been conducted to devise and report detailed ready-to-use protocols for managing PAD to date.
 This study aimed to propose protocols and guidelines for the adult PAD patients&#x2019; standard care. Preparing the protocol, we considered the frequency and type of laboratory tests, imaging, endoscopic examinations, specialist consultations, and standardized recommendations for further care in the place of residence.&#xA0;
As a result of the proposed monitoring scheme, patients can be provided with complete care in terms of their underlying conditions and comorbidities, as well as early detection of complications. This protocol will serve as a guide for physicians dealing with these patients and enable comparisons of patient groups across a variety of treatment centers, even far away from each other.&#xA0;A national consultant in the field of clinical immunology verified the protocol mainly developed by Polish experts from reference immunology centres for adults.&#xA0;
&#xD;

&#xA0;</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/3317</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/3317/1862</pdf_url>
  </Article>
</Articles>
